We are live on ! Find out more
PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$40.6M
Wellington Management Group
2
Wellington Management Group
Massachusetts
$23.8M -$84.3K -20,471 -0.5%
JJIJ
3
Johnson & Johnson Innovation - JJDC
New Jersey
$9.82M +$6.62M +1,607,044 New
RSCM
4
Rock Springs Capital Management
Maryland
$6.87M -$1.2M -291,900 -21%
FCM
5
Farallon Capital Management
California
$6.11M +$791K +192,072 +24%
BlackRock
6
BlackRock
New York
$6.11M +$328K +79,666 +9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$4.53M -$10.3K -2,494 -0.3%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$4.36M -$155K -37,596 -5%
GTC
9
Ghost Tree Capital
New York
$2.75M +$1.85M +450,000 New
DCM
10
DAFNA Capital Management
California
$2.2M
State Street
11
State Street
Massachusetts
$1.4M +$35.2K +8,537 +4%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.16M +$30.4K +7,371 +4%
SAM
13
Sectoral Asset Management
Quebec, Canada
$1.09M -$74.1K -18,000 -9%
BCM
14
Bridgeway Capital Management
Texas
$1.07M +$718K +174,400 New
Stifel Financial
15
Stifel Financial
Missouri
$981K -$166K -40,415 -20%
Northern Trust
16
Northern Trust
Illinois
$870K -$53.7K -13,027 -8%
Goldman Sachs
17
Goldman Sachs
New York
$711K +$27.2K +6,614 +6%
Morgan Stanley
18
Morgan Stanley
New York
$627K -$201K -48,870 -32%
SM
19
Sabby Management
Florida
$576K -$125K -30,437 -24%
PHP
20
Parkman Healthcare Partners
Connecticut
$557K +$375K +91,091 New
TD Asset Management
21
TD Asset Management
Ontario, Canada
$268K +$18.5K +4,500 +11%
Nuveen
22
Nuveen
North Carolina
$226K -$7.75K -1,881 -5%
Charles Schwab
23
Charles Schwab
California
$225K
Bank of New York Mellon
24
Bank of New York Mellon
New York
$217K
First Trust Advisors
25
First Trust Advisors
Illinois
$203K -$2.36K -573 -2%